Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Cytometry. Part B, Clinical Cytometry|November 22, 2021
Dysplasia and PNH-type cells in bone marrow aspirates of myelodysplastic syndromesTheresia M Westers, Canan Alhan, Heleen A Visser-Wisselaar, et al.
Best Practice & Research. Clinical Haematology|February 10, 2015
Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?Eline M P Cremers, Canan Alhan, Theresia M Westers, et al.
British Journal of Haematology|April 15, 2011
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapyShikhar Aggarwal, Arjan A van de Loosdrecht, Canan Alhan, et al.
Immunotherapy|June 4, 2013
Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapyNathalie Kerkhoff, Hetty J Bontkes, Theresia M Westers, et al.
Leukemia Research|April 17, 2012
Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromesHetty J Bontkes, Jurjen M Ruben, Canan Alhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2006
Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targetingIlse Houtenbos, Theresia M Westers, Annemiek Dijkhuis, et al.
Leukemia|March 8, 2024
Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cellsMargot F van Spronsen, Sofie Van Gassen, Carolien Duetz, et al.
Cytometry. Part B, Clinical Cytometry|October 31, 2015
Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerationsCanan Alhan, Theresia M Westers, Eline M P Cremers, et al.
Cytometry. Part B, Clinical Cytometry|December 21, 2021
The flow cytometry myeloid progenitor count: A reproducible parameter for diagnosis and prognosis of myelodysplastic syndromesUlrika Johansson, Neil McIver-Brown, Matthew Cullen, et al.
Frontiers in Oncology|August 12, 2024
The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasmsLuca L G Janssen, Nathalie van Leeuwen-Kerkhoff, Theresia M Westers, et al.
Pageof 8